商品情報
| 検体ID | 税抜金額 | 納期 | 検体名 | 濃度 | Matrix | Age | Gender | カート追加 |
|---|---|---|---|---|---|---|---|---|
| CL-0015-0000055 | 55,000円 | 3営業日後納品 | Alzheimer's disease | K2 EDTA Plasma | 80 | F |
商品詳細
| Date of diagnosis | 2024/8/27 |
| Donor ID | CL36370 |
| Date of Draw | 2024/8/28 |
| Processing | Double spin |
| Volume | 1.0 mL |
| Race | Caucasian |
| Height, cm | 165 |
| Cancer History and Relapses | No |
| HIV, HBV, HCV, RPR | Negative |
| Location Country | Ukraine |
| MMSE | 19 |
| COVID-19 Vaccination | Vaccinated |
| Weight, kg | 80 |
| Smoking History | Non-smoker |
| Drinking History | Non-drinker |
| Note | |
| Treatment | Not treated |
| Concomitant Diseases | No |
| Treatment of Concomitant Diseases | No |
| Lab Tests | N/A |
| Comments Data | "MMSE score: 19; Clinical symptoms: impairment of memory; Date of MRI: 14-May-2024; MRI Conclusion: MRI signs of vascular encephalopathy on a visual scale Fazekas grade 2-3, atrophic changes in brain matter. At the time of examination, there was no evidence of acute cerebrovascular accident or cerebral mass." |